In an effort to combat Alzheimer's disease, scientists are looking at existing drugs that could treat the condition, and a 2025 study identified two promising candidates that are currently used to treat cancer. Already approved by regulators in the US …

- Third quarter total revenues of $278.6 million, up 11% year-over-year - Narrowing and raising high end of NUPLAZID ® net product sales guidance to $685 to $695 million - Updating DAYBUE ® net product sales guidance to $385 to $400 million Acadia …

FOR IMMEDIATE RELEASE Media Contact: Elizabeth Dowling Mount Sinai Press Office 347-541-0212 NewsMedia@mssm.edu Protective Microglia Subtype Offers Potential New Therapeutic Pathway in Alzheimer’s Disease International research team identifies distinct …

Scientists say they need better access to human brain tissue to understand how dementia, Alzheimer's, epilepsy, autism, multiple sclerosis and other brain conditions develop over time.Being able to see how the brain grows, changes and sometimes …

– Marketing Authorization Applications for obicetrapib and FDC of obicetrapib plus ezetimibe accepted for review by European Medicines Agency – – BROOKLYN and BROADWAY pooled MACE analysis published in the Journal of the American College of Cardiology, …

Portfolio Receipts growth of 11% to $814 million; Royalty Receipts growth of 11% Net cash provided by operating activities of $703 million Raised full year 2025 guidance: Portfolio Receipts expected to be $3,200 to $3,250 million NEW YORK, Nov. 05, 2025 ( …

New research from Mass General Brigham shows even modest amounts of exercise can reduce your risk of Alzheimer's disease. And one scientist who has been working in this field for years says there are other simple steps you can take to keep your brain …

Getting in more daily steps may help slow early brain changes linked to Alzheimer's disease, a new long-term study suggests. Researchers followed nearly 300 older adults for up to 14 years and found that people who already showed high levels of beta- …

Ottawa, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The sterile drug product testing market is set to witness robust growth from 2024 to 2034, fueled by the expanding production of biologics and injectable pharmaceuticals. With increasing emphasis on product …

By James Taylor, CBS13 Photojournalist November 3, 2025 / 11:04 PM PST / CBS Sacramento Sacramento's skyline changed colors on Monday night. The capital city is one of 1,500 sites across the nation taking part in the annual Light the World in …